Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series-Reference-Cited by-同舟云学术

Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series

Published:2014-10-01 Issue:1 Volume:4 Page:
ISSN:2045-3329
Container-title:Clinical Sarcoma Research
language:en
Short-container-title:Clin Sarcoma Res

Author:

Verschoor Arie J,Gelderblom Hans

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1186/2045-3329-4-14.pdf

Reference16 articles.

1. ESMO/European Sarcoma Network Working Group: Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012, 23 (Suppl 7): vii92-vii99.

2. Sleijfer S, Seynaeve C, Verweij J: Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care. Oncologist. 2005, 10 (10): 833-841. 10.1634/theoncologist.10-10-833

3. Le Cesne A, Blay JY, Judson I, Van Oosterom A, Verweij J, Radford J, Lorigan P, Rodenhuis S, Ray-Coquard I, Bonvalot S, Collin F, Jimeno J, Di Paola E, Van Glabbeke M, Nielsen OS: Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. J Clin Oncol. 2005, 23 (3): 576-584.

4. Demetri GD, Chawla SP, von Mehren M, Ritch P, Baker LH, Blay JY, Hande KR, Keohan ML, Samuels BL, Schuetze S, Lebedinsky C, Elsayed YA, Izquierdo MA, Gomez J, Park YC, Le Cesne A: Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. J Clin Oncol. 2009, 27 (25): 4188-4196. 10.1200/JCO.2008.21.0088

5. van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, Schoffski P, Aglietta M, Staddon AP, Beppu Y, Le Cesne A, Gelderblom H, Judson IR, Araki N, Ouali M, Marreaud S, Hodge R, Dewji MR, Coens C, Demetri GD, Fletcher CD, Dei Tos AP, Hohenberger P, : Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2012, 379 (9829): 1879-1886. 10.1016/S0140-6736(12)60651-5

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib-induced severe bilateral pneumothorax: A case report;Medicine;2024-01-19

2. A case of surgical intervention for refractory pneumothorax associated with pulmonary metastases from osteosarcoma during pazopanib administration;The Journal of the Japanese Association for Chest Surgery;2024-01-15

3. Pneumothorax: Imaging Diagnosis and Etiology;Seminars in Roentgenology;2023-10

4. UNDIFFERENTIATED PLEOMORPHIC SARCOMA, PAZOPANIB, AND SECONDARY SPONTANEOUS PNEUMOTHORAX;CHEST;2023-10

5. Stereotactic body radiation therapy for sarcoma pulmonary metastases;Radiotherapy and Oncology;2023-10